title: Primary hyperoxaluria type 1 in Tunisian children.
abstract: To determine the clinical, biological, and radiological futures of primary hyper-oxaluria type 1 in Tunisian children, we retrospectively studied 44 children with primary hyper-oxaluria type 1 who were treated in our center from 1995 to 2009. The diagnosis was established by quantitative urinary oxalate excretion. In patients with renal impairment, the diagnosis was made by infrared spectroscopy of stones or kidney biopsies. The male-to-female ratio was 1:2. The median age at diagnosis was 5.75 years. About 43% of the patients were diagnosed before the age of five years with initial symptoms dominated by uremia. Four patients were asymptomatic and diagnosed by sibling screenings of known patients. Nephrocalcinosis was present in all the patients; it was cortical in 34%, medullary in 32%, and global in 34%. At diagnosis, 12 (27%) children were in end-stage renal disease. Pyridoxine response, which is defined by a reduction in urine oxalate excretion of 60% or more, was obtained in 27% of the cases. In the majority of patients, the clinical expression of primary hyperoxaluria type 1 was characterized by nephrocalcinosis, urolithiasis, and renal failure; pyridoxine sensitivity was associated with better outcome.
authors.affiliation: Department of Pediatric Nephrology, Charles Nicolle Hospital, Tunis, Tunisia. kitomora@yahoo.fr
authors.forename: Tahar
authors.initials: T
authors.lastname: Gargah
authors.forename: Nourchene
authors.initials: N
authors.lastname: Khelil
authors.forename: Gharbi
authors.initials: G
authors.lastname: Youssef
authors.forename: Wiem
authors.initials: W
authors.lastname: Karoui
authors.forename: Mohamed Rachid
authors.initials: MR
authors.lastname: Lakhoua
authors.forename: Jaouida
authors.initials: J
authors.lastname: Abdelmoula
mesh_terms: D002675:Child, Preschool; D005260:Female; D006801:Humans; D006960:Hyperoxaluria, Primary / Q000150:complications / Q000175:diagnosis*; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D009397:Nephrocalcinosis / Q000150:complications / Q000000981:diagnostic imaging / Q000473:pathology; D010070:Oxalates / Q000652:urine*; D012189:Retrospective Studies; D014416:Tunisia; D014463:Ultrasonography; D014511:Uremia / Q000150:complications; D052878:Urolithiasis / Q000150:complications
chemical_list: D010070:Oxalates